Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Catherine Royce"'
Autor:
Asrat Hailu, Ahmed Musa, Monique Wasunna, Manica Balasegaram, Sisay Yifru, Getahun Mengistu, Zewdu Hurissa, Workagegnehu Hailu, Teklu Weldegebreal, Samson Tesfaye, Eyasu Makonnen, Eltahir Khalil, Osama Ahmed, Ahmed Fadlalla, Ahmed El-Hassan, Muzamil Raheem, Marius Mueller, Yousif Koummuki, Juma Rashid, Jane Mbui, Geoffrey Mucee, Simon Njoroge, Veronica Manduku, Alice Musibi, Geoffrey Mutuma, Fredrick Kirui, Hudson Lodenyo, Dedan Mutea, George Kirigi, Tansy Edwards, Peter Smith, Lawrence Muthami, Catherine Royce, Sally Ellis, Moses Alobo, Raymond Omollo, Josephine Kesusu, Rhoda Owiti, John Kinuthia, Leishmaniasis East Africa Platform (LEAP) group
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 4, Iss 10, p e709 (2010)
Visceral leishmaniasis (VL) is a major health problem in developing countries. The untreated disease is fatal, available treatment is expensive and often toxic, and drug resistance is increasing. Improved treatment options are needed. Paromomycin was
Externí odkaz:
https://doaj.org/article/a53d30a0c578481b92f81187f981e8ec
Autor:
Ahmed M Musa, Brima Younis, Ahmed Fadlalla, Catherine Royce, Manica Balasegaram, Monique Wasunna, Asrat Hailu, Tansy Edwards, Raymond Omollo, Mahmoud Mudawi, Gilbert Kokwaro, Ahmed El-Hassan, Eltahir Khalil
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 4, Iss 10, p e855 (2010)
A recent study has shown that treatment of visceral leishmaniasis (VL) with the standard dose of 15 mg/kg/day of paromomycin sulphate (PM) for 21 days was not efficacious in patients in Sudan. We therefore decided to test the efficacy of paramomycin
Externí odkaz:
https://doaj.org/article/391462a9ef5a4d678b54f969996a7060
Publikováno v:
PLoS Medicine, Vol 3, Iss 6, p e282; author reply e284 (2006)
Externí odkaz:
https://doaj.org/article/e08145d84808479ba3c0110e5c5b5634
Publikováno v:
PLoS Medicine, Vol 2, Iss 7, p e211 (2005)
Externí odkaz:
https://doaj.org/article/2ff60e657b564e85b79734852066f514
Autor:
Jill Adler-Moore, Dimitris A Kafetzis, Luigi Gradoni, Concepcion Figueras, Juan Berenguer, Jorge Alvar, Catherine Royce, Margriet den Boer, R. Russo, Eric Rosenthal, Koert Ritmeijer, Caryn Bern, Marleen Boelaert, Robert N. Davidson, Shyam Sundar
Publikováno v:
Clinical Infectious Diseases. 43:917-924
During the past decade, liposomal amphotericin B has been used with increasing frequency to treat visceral leishmaniasis (VL). The World Health Organization convened a workshop to review current knowledge and to develop guidelines for liposomal ampho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49d14cf0d3fa1c9e588d34b3aa97afd5
https://doi.org/10.1086/507530
https://doi.org/10.1086/507530
Autor:
Hilary A. Chaudri, Catherine Royce, Patrick Trunet, Ajay S. Bhatnagar, Franzanne Vreeland, Judy Cooper
Publikováno v:
The Journal of Steroid Biochemistry and Molecular Biology. 61:241-245
The aim of endocrine therapy is to reduce the estrogenic stimulus for tumour growth. After failure of tamoxifen — the standard “first-line” hormonotherapy for advanced breast cancer (ABC) — the most frequently prescribed endocrine therapies a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::553ff7d6170d193cf80a593e3ad95839
https://doi.org/10.1016/s0960-0760(97)80018-0
https://doi.org/10.1016/s0960-0760(97)80018-0
Autor:
Sisay Yifru, Monique Wasunna, Tansy Edwards, Asrat Hailu, Ahmed Eleojo Musa, Brima Musa, Manica Balasegaram, Catherine Royce, Sally Ellis, Eltahir A G Khalil, Pete Smith, Raymond Omollo
Publikováno v:
Trials
Trials, Vol 12, Iss 1, p 66 (2011)
Trials, Vol 12, Iss 1, p 66 (2011)
Background AmBisome® is an efficacious, safe anti-leishmanial treatment. There is growing interest in its use, either as a single dose or in combination treatments. In East Africa, the minimum optimal single-dosage has not been identified. Methods/D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f09d82ef801c0fe6bd5242338e17393d
https://pubmed.ncbi.nlm.nih.gov/21375777
https://pubmed.ncbi.nlm.nih.gov/21375777
Autor:
Pete Smith, Yousif Koummuki, Ahmed Fadlalla, Raymond Omollo, Sisay Yifru, Veronica Manduku, Lawrence Muthami, Osama Ahmed, Monique Wasunna, Manica Balasegaram, Muzamil Raheem, Eyasu Makonnen, Eltahir A G Khalil, Sally Ellis, Ahmed M. Elhassan, J. R. Rashid, Samson Tesfaye, Fredrick Kirui, Hudson A. Lodenyo, Jane Mbui, Rhoda Owiti, Geoffrey Mucee, Marius Mueller, Moses Alobo, Dedan Mutea, Zewdu Hurissa, Tansy Edwards, Josephine Kesusu, Asrat Hailu, Getahun Mengistu, Simon Njoroge, Workagegnehu Hailu, Geoffrey Mutuma, Teklu Weldegebreal, Catherine Royce, Alice Musibi, John Kinuthia, G. Kirigi, Ahmed Eleojo Musa
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 4, Iss 10, p e709 (2010)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
Background Visceral leishmaniasis (VL) is a major health problem in developing countries. The untreated disease is fatal, available treatment is expensive and often toxic, and drug resistance is increasing. Improved treatment options are needed. Paro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cf334d1868446a60e5e9cf516eddd64
http://hdl.handle.net/10144/127587
http://hdl.handle.net/10144/127587
Autor:
Gilbert Kokwaro, Ahmed Fadlalla, Raymond Omollo, Ahmed Eleojo Musa, Mahmoud Mudawi, Brima M. Younis, Catherine Royce, Monique Wasunna, Manica Balasegaram, Asrat Hailu, Ahmed M. Elhassan, Eltahir A G Khalil, Tansy Edwards
Publikováno v:
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Vol 4, Iss 10, p e855 (2010)
PLoS Neglected Tropical Diseases, Vol 4, Iss 10, p e855 (2010)
Background A recent study has shown that treatment of visceral leishmaniasis (VL) with the standard dose of 15 mg/kg/day of paromomycin sulphate (PM) for 21 days was not efficacious in patients in Sudan. We therefore decided to test the efficacy of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ce8a30451419be8b1797d2e8a799186
http://europepmc.org/articles/PMC2964291
http://europepmc.org/articles/PMC2964291
Autor:
Caryn, Bern, Jill, Adler-Moore, Juan, Berenguer, Marleen, Boelaert, Margriet, den Boer, Robert N, Davidson, Concepcion, Figueras, Luigi, Gradoni, Dimitris A, Kafetzis, Koert, Ritmeijer, Eric, Rosenthal, Catherine, Royce, Rosario, Russo, Shyam, Sundar, Jorge, Alvar
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 43(7)
During the past decade, liposomal amphotericin B has been used with increasing frequency to treat visceral leishmaniasis (VL). The World Health Organization convened a workshop to review current knowledge and to develop guidelines for liposomal ampho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bf18e6f3027b82ab642a53436627fecd
https://pubmed.ncbi.nlm.nih.gov/16941377
https://pubmed.ncbi.nlm.nih.gov/16941377